Pharma

Also: Blood glucose monitoring could be coming to next-gen consumer smartwatches; new incubator looking for disruptive health tech startups.

Asset Management Ventures' Skip Fleshman outlines COVID-19's impact on clinical trials and the resulting leap toward tech-enabled decentralized trials.

The pair will meet quarterly to discuss possible integrations and collaborations with the pharma industry. 

The results will not impact the current rollout of a new version of the app, under special FDA guidelines.

The research project will be conducted using the Apple Watch and iPhone, and is set to begin during 2021.

The Cairo-based health tech startup’s founder revealed plans for the company’s expansion, with “an aggressive plan to cover MENA and Africa in the foreseeable future.”

The London-based company is backing a 300-person UPenn study comparing its digital therapeutic to the consumer wellness app.

This week's top stories include the vaccine distribution pipeline facing security risks as the UK begins administering the Pfizer COVID-19 vaccine, and Google rolling out an app that shows participants how their data is driving health insights.

The tool was designed to help patients and caregivers manage the condition and treatment.